DOI: 10.1055/s-00000069

Seminars in Liver Disease

References

Park BH, Hwang T, Liu TC. , et al.
Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial.

Lancet Oncol 2008;
9 (06) 533-542

Download Bibliographical Data

Access:
Access:
Access: